Ji Qiu, Arizona State University (IMAGE)
Caption
A new study, led by Biodesign scientists Josh LaBaer and Ji Qiu (pictured), along with gastroenterologists Shabana Pasha and Jonathan Leighton from Mayo Clinic Arizona, successfully identified several molecules, called biomarkers, that were unique indicators found only in patients with Crohn's disease.
Credit
Biodesign Institute, ASU
Usage Restrictions
None
License
Licensed content